Skip to main content

Test Price

850 AED

✅ Home Collection Available

Hyperthyroidism & Graves’ Disease Panel in UAE | 850 AED | DHA Accredited Laboratory

Executive Summary & Core Metrics

Our DHA-accredited laboratory delivers 99.9% diagnostic sensitivity for the Hyperthyroidism / Graves’ Disease Panel using advanced chemiluminescent and electrochemiluminescent immunoassays, paired with premium VIP mobile phlebotomy and temperature-controlled cold-chain home collection.

  • 99.9% Diagnostic Sensitivity – ISO-accredited processing guarantees clinically validated results.
  • Hospital‑Grade Home Collection – VIP mobile phlebotomy with ISO‑certified cold‑chain transport , available daily from 8 AM to 11 PM.
  • Telephonic Clinical Guidance – Post‑test interpretation support from experienced medical professionals.
  • Direct Insurance Billing – WhatsApp verification at +971 54 548 8731.

Test Overview & Methodology

This panel simultaneously measures TSH, Free T3, Free T4 and thyroid‑stimulating immunoglobulins (Graves’ antibodies) to accurately diagnose hyperthyroidism and autoimmune Graves’ disease in one blood draw, using state-of-the-art chemiluminescent and electrochemiluminescent immunoassay platforms.

Feature Our Test (DHA Accredited) Closest Alternative
Precision 99.9% sensitivity, CLIA+ECLIA (gold standard) ~95% sensitivity, standard CLIA only
Method Chemiluminescent + Electrochemiluminescent Immunoassay Basic chemiluminescence, single platform
Turnaround Time Same day (sample by 4 PM) 24–48 hours
Graves’ Antibodies Included (TSH receptor antibodies) Often separate, extra cost
Price 850 AED 500–700 AED (basic panel)

Physician Insight & Safety Protocols

Dr. Ajay Singh, DHA‑licensed General Practitioner (License 36234132), shares: “A comprehensive thyroid panel that includes TSH receptor antibodies is invaluable when hyperthyroidism is suspected. However, laboratory values must always be correlated with a thorough clinical assessment. Patients frequently ask whether they can adjust their thyroid medication based on test results — this is never advisable. Always consult your physician for a complete interpretation of your hormonal profile in the context of your overall health status.”

Important Medication Advisory

DO NOT discontinue or adjust any prescribed thyroid medication such as methimazole, propylthiouracil, propranolol, or levothyroxine based solely on your test results. Only your treating physician can safely modify your medication regimen.

Safety Exclusion Criteria & Red Flags

  • Active thyroid storm characterised by fever above 38.5°C, severe tachycardia, or agitation — seek emergency hospital care immediately rather than home collection.
  • Unstable cardiac arrhythmia such as atrial fibrillation with rapid ventricular rate or symptomatic bradycardia requires urgent medical evaluation.
  • Acute eye pain, vision loss, or worsening exophthalmos may necessitate orbital decompression and specialist ophthalmology review.
  • Severe involuntary weight loss exceeding 10% of body mass over the preceding three months accompanied by proximal muscle weakness.
  • Known pregnancy with uncontrolled hyperthyroidism requires dedicated maternal‑fetal specialist monitoring and coordinated care.
  • If you experience chest pain, syncopal episodes, or sudden confusion, proceed directly to the nearest emergency department without waiting for laboratory results.

Patient FAQ & Clinical Guidance

1. What does the Hyperthyroidism / Graves’ Disease Panel measure?

This test measures TSH, Free T3, Free T4, and thyroid‑stimulating immunoglobulins (TSH receptor antibodies) using advanced CLIA/ECLIA methodology for comprehensive hyperthyroidism diagnosis. It directly quantifies both circulating thyroid hormones and the autoimmune antibodies responsible for Graves’ disease, enabling your physician to distinguish autoimmune hyperthyroidism from other thyrotoxic states and tailor treatment with precision.

2. How should I prepare for this blood test?

No special preparation is required. Our VIP mobile phlebotomist will collect a venous blood sample under strict cold‑chain conditions ensuring 99.9% diagnostic accuracy. You do not need to fast, but please inform the phlebotomist if you are taking any biotin supplements or have had recent iodine‑based contrast exposure, as these may interfere with certain immunoassays. Continue all prescribed medications unless your physician has specifically advised otherwise.

3. When will I receive my test results?

Results are reported on the same day when your sample is collected before 4 PM. Your report is uploaded securely to our patient portal and reviewed by our clinical team. You may schedule a complimentary tele‑consultation to discuss the findings and determine appropriate next steps. Never adjust thyroid medication dosage based solely on numerical values — always involve your treating physician.

4. Can this test distinguish Graves’ disease from other causes of hyperthyroidism?

Yes, the inclusion of TSH receptor antibodies specifically identifies autoimmune Graves’ disease with high sensitivity and specificity. Elevated antibody levels in conjunction with suppressed TSH and elevated free thyroid hormones strongly suggest Graves’ disease rather than toxic nodular goiter, thyroiditis, or factitious thyrotoxicosis. Your physician will integrate these results with clinical findings and, if indicated, thyroid imaging for a definitive diagnosis.

UAE Regulatory & Data Privacy Adherence

Healthcare Compliance & Data Protection Framework

This diagnostic service operates under the regulatory oversight of the Dubai Health Authority (DHA) and complies fully with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) governing the secure collection, processing, and storage of patient health information. All clinical data handling adheres to Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields, ensuring electronic health records meet stringent security standards. Patient consent and clinical safety protocols are aligned with Federal Decree-Law No. 4 of 2016 on Medical Liability. DNA Labs UAE is ISO 9001:2015 certified and maintains rigorous quality management systems for laboratory diagnostics.

Clinical & Logistical Metadata

Test Name Hyperthyroidism / Graves’ Disease Panel (TSH, Free T3, Free T4, TSH Receptor Antibodies)
Price (AED) 850 AED
Turnaround Time Same day (sample received by 4 PM); results uploaded to secure patient portal
Sample Type / Matrix Venous whole blood (serum separator tube); VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection available daily 8 AM – 11 PM
Methodology Used Chemiluminescent Immunoassay (CLIA) and Electrochemiluminescent Immunoassay (ECLIA)
ICD-10-CM Code E05.90 (Hyperthyroidism, unspecified)
LOINC Code 24320-4 (Thyroid panel)
DHA Facility License & Laboratory Address DHA Facility License Number: 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | DNA Labs UAE

دعم ثنائي اللغة متاح

التحقق من التغطية التأمينية

Check Insurance Coverage Instantly

Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.

توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.

✅ DHA Certified ✅ ISO 15189 ✅ HIPAA Compliant

Available in Arabic, English, Hindi & Urdu

🏅

ISMS 27001:2022

📋

ISO Accredited

🔒

HIPAA

All reports reviewed by DHA-Certified physicians